Elevance Health Inc.

NYSE:ELV

Medical - Healthcare Plans

Healthcare
$400.84 -0.88%

-$3.45 today

Market cap
$86.60B
Beta
0.68
P/E (TTM)
16.3
EPS (TTM)
$23.78
Dividend yield
1.77%
52W Low $273.71High $426.98

Volume 1.91M

Average 1.68M

ELV Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Elevance Health Inc.NYSE: ELV

Revenue · Q3 FY2026 · quarter ended Sep 2026

Revenue grows, but more slowly than its trailing trend

Q3 FY2026 revenue of $51.43B rose 1.4% year over year, behind the +3.6% change in trailing-twelve-month revenue. Sequentially, it rose 1.9% from the prior quarter. Over 3 fiscal years it compounded at +8.3% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 12 analysts of $200.07B (+0.5%) for the fiscal year ending Dec 2026, a slowdown from the +12.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$51.43B+1.9% QoQ
Last fiscal yearDec 2025
$199.13B+12.6% YoY
LTMSep 2026
$201.83B+3.6% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.4%-0.7%-2.2 pp
1 year+12.6%+0.5%-12.1 pp
3-year CAGR+8.3%+2.3%-6.0 pp
5-year CAGR+3.6%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
199.13B USD
Year-over-year change
+12.6%
4-year CAGR
+9.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How ELV compares with its peers on the latest reported figures

  • ELV's LTM Sep 2026 revenue of $201.83B is the 4th highest of the 9 companies compared; the peer median is $173.96B.
  • Its year-over-year change of +3.6% is the 7th highest of 9, against a peer median of +8.0%.
  • Over three fiscal years its annual growth of +8.3% compares with a peer median of +12.1%.
ELV Competitors Peer median
Revenue for ELV and competitors
Company Period LTM YoY 3-year CAGR
UNHUnitedHealth Group IncorporatedLTM Sep 2026$449.66B +3.3%+11.4%
CVSCVS Health CorporationLTM Jun 2026$415.09B +7.4%+7.6%
CICigna CorporationLTM Sep 2026$286.32B +6.8%+15.1%
ELVElevance Health Inc.LTM Sep 2026$201.83B +3.6%+8.3%
CNCCentene CorporationLTM Jun 2026$193.73B +8.7%+10.5%
HUMHumana Inc.LTM Sep 2026$154.19B +22.0%+11.7%
MOHMolina Healthcare, Inc.LTM Sep 2026$43.63B -2.1%+12.4%
OSCROscar Health, Inc.LTM Jun 2026$15.32B +42.8%+41.6%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$4.26B +41.8%+40.2%
Peer median (excluding ELV) $173.96B+8.0%+12.1%

Competitors are the stored peer set for ELV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue138.64B156.6B171.34B176.81B199.13B
Cost of Revenue102.65B116.64B124.33B127.57B148.22B
Gross Profit35.99B39.95B47.01B49.24B50.9B
Gross Margin26.0%25.5%27.4%27.9%25.6%
Research & Development00000
Selling, General & Admin00000
Operating Expenses27.05B31.5B38.27B40.36B42.79B
Depreciation & Amortization1.3B1.68B1.75B1.39B1.55B
EBITDA10.03B10.13B10.49B10.48B9.66B
EBITDA Margin7.2%6.5%6.1%5.9%4.9%
Operating Income8.95B8.45B8.75B8.89B8.11B
Operating Margin6.5%5.4%5.1%5.0%4.1%
Interest Income00000
Interest Expense798M851M1.03B1.19B1.4B
Other Income / Expenses(1.02B)(851M)(1.03B)(984M)(1.4B)
Income Before Tax7.93B7.6B7.72B7.9B6.71B
Pre-Tax Margin5.7%4.9%4.5%4.5%3.4%
Income Tax Expense1.83B1.71B1.72B1.93B1.05B
Net Income6.1B5.89B5.99B5.98B5.66B
Net Margin4.4%3.8%3.5%3.4%2.8%
EPS (Basic)25.2524.5625.3825.8125.18
EPS (Diluted)24.7324.2825.2225.6825.12
Weighted Avg Shares243.8M240M233.07M232.87M221.8M
Weighted Avg Shares (Diluted)246.8M242.8M237.4M232.9M221.8M

Elevance Health Inc.

NYSE:ELV

Intrinsic Alpha fair value

Locked

Current Price

$400.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.